BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 14972783)

  • 1. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
    Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
    Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
    Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
    Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH) syndromes and expansion mechanism of a PNH clone.
    Shichishima T; Noji H
    Int J Hematol; 2006 Aug; 84(2):97-103. PubMed ID: 16926129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
    Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
    Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.
    Ware RE; Pickens CV; DeCastro CM; Howard TA
    Exp Hematol; 2001 Dec; 29(12):1403-9. PubMed ID: 11750098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxysmal nocturnal hemoglobinuria: stem cells and clonality.
    Brodsky RA
    Hematology Am Soc Hematol Educ Program; 2008; ():111-5. PubMed ID: 19074067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria.
    Ware RE; Nishimura J; Moody MA; Smith C; Rosse WF; Howard TA
    Blood; 1998 Oct; 92(7):2541-50. PubMed ID: 9746796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Tiu R; Maciejewski J
    Int J Hematol; 2006 Aug; 84(2):113-7. PubMed ID: 16926131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxysmal nocturnal hemoglobinuria clone in bone marrow of patients with pancytopenia.
    Nakakuma H; Nagakura S; Iwamoto N; Kawaguchi T; Hidaka M; Horikawa K; Kagimoto T; Shido T; Takatsuki K
    Blood; 1995 Mar; 85(5):1371-6. PubMed ID: 7532041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].
    Röth A; Dührsen U; Schrezenmeier H; Schubert J
    Dtsch Med Wochenschr; 2009 Feb; 134(9):404-9. PubMed ID: 19224425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
    Kawaguchi T; Nakakuma H
    Int J Hematol; 2007 Jul; 86(1):27-32. PubMed ID: 17675263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
    Mevorach D
    Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of paroxysmal nocturnal hemoglobinuria.
    Rosti V
    Haematologica; 2000 Jan; 85(1):82-7. PubMed ID: 10629597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Stem Cells; 1996 Jul; 14(4):396-411. PubMed ID: 8843541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Wilms' tumor gene peptide-specific cytotoxic T lymphocytes in immunologic selection of a paroxysmal nocturnal hemoglobinuria clone.
    Ikeda K; Shichishima T; Yasukawa M; Nakamura-Shichishima A; Noji H; Akutsu K; Osumi K; Maruyama Y
    Exp Hematol; 2007 Apr; 35(4):618-26. PubMed ID: 17379072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
    Mannelli F; Bencini S; Peruzzi B; Cutini I; Sanna A; Benelli M; Magi A; Gianfaldoni G; Rotunno G; Carrai V; Gelli AM; Valle V; Santini V; Notaro R; Luzzatto L; Bosi A
    Cytometry B Clin Cytom; 2013 Mar; 84(2):71-81. PubMed ID: 23281097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of T Lymphocytes in the Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
    Li C; Dong X; Wang H; Shao Z
    Front Immunol; 2021; 12():777649. PubMed ID: 35003092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Luzzatto L; Bessler M
    Curr Opin Hematol; 1996 Mar; 3(2):101-10. PubMed ID: 9372059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.